Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

Summary

This is a double-blind, randomized, placebo-controlled multi-center phase IIA study to evaluate the clinical efficacy and safety of Fugan ointment versus placebo applied to involved skin of subjects with mild to moderate subacute eczema.

Timeline

Start

2017-04-26

Primary completion

2018-05-25

Completion

2018-09-10

Outcome

Missed primary endpoint

release “Although the study showed that topical ZL-3101 was safe and well-tolerated, the treatment showed no difference compared to placebo in the primary efficacy endpoint” zailaboratory.com ↗

Drugs

Indications